APEX1 and gastric cancer: Furthermore, our study pointed out that dose-dependent AT101 displayed suppression of gastric cancer cell migration, meanwhile, decreasing cell renewal markers-CD133, Nanog and LC3 expression after inhibition of APE1 expression.